Patents by Inventor Gazelle S. Rastegar

Gazelle S. Rastegar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 103P2D6: tissue specific protein highly expressed in various cancers
    Patent number: 7534417
    Abstract: A novel gene (designated 103P2D6) and its encoded protein are described. 103P2D6 is not expressed in normal adult tissue, but is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in prostate cancer. 103P2D6 is also expressed in some fetal tissues, and in breast, bladder, lung, bone, colon, pancreatic, testicular, cervical and ovarian cancers. Consequently, 103P2D6 provides a diagnostic and/or therapeutic target for cancers, and the 103P2D6 gene or fragment thereof, or its encoded protein or a fragment thereof can be used to elicit an immune response.
    Type: Grant
    Filed: February 26, 2001
    Date of Patent: May 19, 2009
    Assignee: Agensys, Inc.
    Inventors: Arthur B. Raitano, Daniel E. H. Afar, Gazelle S. Rastegar, Steve Chappell Mitchell, Rene S. Hubert, Pia M. Challita-Eid, Mary Faris, Aya Jakobovits
  • 103P2D6: tissue specific protein highly expressed in various cancers
    Patent number: 7199220
    Abstract: A novel gene (designated 103P2D6) and its encoded protein are described. 103P2D6 is not expressed in normal adult tissue, but is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in prostate cancer. 103P2D6 is also expressed in some fetal tissues, and in breast, bladder, lung, bone, colon, pancreatic, testicular, cervical and ovarian cancers. Consequently, 103P2D6 provides a diagnostic and/or therapeutic target for cancers, and the 103P2D6 gene or fragment thereof, or its encoded protein or a fragment thereof can be used to elicit an immune response.
    Type: Grant
    Filed: October 29, 2002
    Date of Patent: April 3, 2007
    Assignee: Agensys, Inc.
    Inventors: Arthur B. Raitano, Daniel E. H. Afar, Gazelle S. Rastegar, Steve Chappell Mitchell, Rene S. Hubert, Pia M. Challita-Eid, Mary Faris, Aya Jakobovits
  • 103P2D6: tissue specific protein highly expressed in various cancers
    Patent number: 7172898
    Abstract: A novel gene (designated 103P2D6) and its encoded protein are described. 103P2D6 is not expressed in normal adult tissue, but is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in prostate cancer. 103P2D6 is also expressed in some fetal tissues, and in breast, bladder, lung, bone, colon, pancreatic, testicular, cervical and ovarian cancers. Consequently, 103P2D6 provides a diagnostic and/or therapeutic target for cancers, and the 103P2D6 gene or fragment thereof, or its encoded protein or a fragment thereof can be used to elicit an immune response.
    Type: Grant
    Filed: October 29, 2002
    Date of Patent: February 6, 2007
    Assignee: Agensys, Inc.
    Inventors: Arthur B. Raitano, Daniel E. H. Afar, Gazelle S. Rastegar, Steve Chappell Mitchell, Rene S. Hubert, Pia M. Challita-Eid, Mary Faris, Aya Jakobovits
  • 103P2D6: tissue specific protein highly expressed in various cancers
    Publication number: 20030219766
    Abstract: A novel gene (designated 103P2D6) and its encoded protein are described. 103P2D6 is not expressed in normal adult tissue, but is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in prostate cancer. 103P2D6 is also expressed in some fetal tissues, and in breast, bladder, lung, bone, colon, pancreatic, testicular, cervical and ovarian cancers. Consequently, 103P2D6 provides a diagnostic and/or therapeutic target for cancers, and the 103P2D6 gene or fragment thereof, or its encoded protein or a fragment thereof can be used to elicit an immune response.
    Type: Application
    Filed: October 29, 2002
    Publication date: November 27, 2003
    Inventors: Arthur B. Raitano, Daniel E.H. Afar, Gazelle S. Rastegar, Steve Chappell Mitchell, Rene S. Hubert, Pia M. Challita-Eid, Mary Faris, Aya Jakobovits
  • 103P2D6: tissue specific protein highly expressed in various cancers
    Publication number: 20030194407
    Abstract: A novel gene (designated 103P2D6) and its encoded protein are described. 103P2D6 is not expressed in normal adult tissue, but is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in prostate cancer. 103P2D6 is also expressed in some fetal tissues, and in breast, bladder, lung, bone, colon, pancreatic, testicular, cervical and ovarian cancers. Consequently, 103P2D6 provides a diagnostic and/or therapeutic target for cancers, and the 103P2D6 gene or fragment thereof, or its encoded protein or a fragment thereof can be used to elicit an immune response.
    Type: Application
    Filed: October 29, 2002
    Publication date: October 16, 2003
    Inventors: Arthur B. Raitano, Daniel E.H. Afar, Gazelle S. Rastegar, Steve Chappell Mitchell, Rene S. Hubert, Pia M. Challita-Eid, Mary Faris, Aya Jakobovits
  • 103P2D6: tissue specific protein highly expressed in various cancers
    Publication number: 20030157597
    Abstract: A novel gene (designated 103P2D6) and its encoded protein are described. 103P2D6 is not expressed in normal adult tissue, but is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in prostate cancer. 103P2D6 is also expressed in some fetal tissues, and in breast, bladder, lung, bone, colon, pancreatic, testicular, cervical and ovarian cancers. Consequently, 103P2D6 provides a diagnostic and/or therapeutic target for cancers, and the 103P2D6 gene or fragment thereof, or its encoded protein or a fragment thereof can be used to elicit an immune response.
    Type: Application
    Filed: February 26, 2001
    Publication date: August 21, 2003
    Inventors: Arthur B. Raitano, Daniel E.H. Afar, Gazelle S. Rastegar, Steve Chappell Mitchell, Rene S. Hubert, Pia M. Challita-Eid, Mary Faris, Aya Jakobovits